| Followers | 2583 |
| Posts | 329728 |
| Boards Moderated | 23 |
| Alias Born | 04/12/2001 |
Thursday, February 15, 2024 5:56:32 PM
Sometimes it's better not to offer a lengthy defense, especially if you once did business with a Turkish magician who had no medical or scientific credentials, and hired a hitman to murder a victim of one of his scams. I find it just weird that current management doesn't seem embarrassed about that.
Recent LNAI News
- Federal Judge Orders Expedited Discovery to Identify 'John Doe' Defendants 'Naked' Short-Sellers of Lunai Common Stock • PR Newswire (US) • 05/22/2026 01:15:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/20/2026 01:15:29 PM
- LUNAI BIOWORKS, INC. ANNOUNCES REVERSE STOCK SPLIT • PR Newswire (US) • 05/20/2026 01:15:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/15/2026 08:46:02 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/13/2026 08:45:41 PM
- CNS Drug Delivery Technologies Are Reshaping Alzheimer's and Biodefense Research • InvestorsHub NewsWire • 05/13/2026 01:00:00 PM
- CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research • GlobeNewswire Inc. • 05/13/2026 12:30:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 05/11/2026 09:30:26 PM
- Lunai Bioworks Completes $20 Million Preferred Issuance to Acquire CNS Delivery and Neurotherapeutic IP • PR Newswire (US) • 05/04/2026 01:35:00 PM
- Form DEFR14A - Revised definitive proxy soliciting materials • Edgar (US Regulatory) • 05/01/2026 09:18:22 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/01/2026 09:17:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 09:30:26 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/28/2026 09:00:31 PM
- Lunai Bioworks Unit Signs Preliminary Deal with Geneial on Rare Disease Data Collaboration • IH Market News • 04/15/2026 02:54:51 PM
- Lunai Bioworks (NASDAQ: LNAI) and Geneial Sign LOI to Build Rare Disease Patient Cohorts for Pharma Partnerships • PR Newswire (US) • 04/15/2026 01:10:00 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/13/2026 09:15:39 PM
- Lunai Bioworks unit secures defense collaboration for AI chemical threat platform • IH Market News • 04/07/2026 01:44:38 PM
- Lunai Bioworks (NASDAQ: LNAI) Secures First Revenue-Generating Defense Collaboration Through BioSymetrics, Deploying AI Platform for Chemical Threat Assessment; Additional Engagements Under Discussion • PR Newswire (US) • 04/07/2026 01:05:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/02/2026 09:01:42 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/30/2026 09:35:01 PM
- Lunai Bioworks to acquire CNS drug delivery platform and Alzheimer’s assets for $20M • IH Market News • 03/26/2026 03:21:42 PM
- Lunai Bioworks Executes $20M Strategic Transaction at Fixed $1.50 Conversion, Acquiring BBB Delivery Platform for CNS Alzheimer's Therapies with Broad CNS Delivery Applications • PR Newswire (US) • 03/26/2026 12:50:00 PM
- Lunai Bioworks (NASDAQ: LNAI) Launches National Chemical Defense Consortium Targeting $400M-$1.2B U.S. Countermeasure Programs; 3-Year AI Antidote Development Model • PR Newswire (US) • 03/19/2026 01:57:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/05/2026 09:46:11 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2026 09:33:21 PM
